Peer Review History

Original SubmissionNovember 14, 2024
Decision Letter - Adélia Sequeira, Editor

-->PONE-D-24-51917-->-->An anatomically informed computational fluid dynamics modeling approach for quantifying hemodynamics in the developing heart-->-->PLOS ONE

Dear Dr. Bressan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> -->-->Please submit your revised manuscript by Mar 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Adélia Sequeira, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating in your Funding Statement: 

This work is supported by the American Heart Association Predoctoral fellowship 899419 to K Giesbrecht. 

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. 

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

Light sheet fluorescence microscopy was performed at the Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine. Research reported in this publication was supported in part by the North Carolina Biotech Center Institutional Support Grant 2016-IDG-1016. Imaris segmentation was performed using the Imaris software at the UNC Hooker Imaging Core Facility. The UNC Hooker Imaging Core Facility and the Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine are both supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. All figures were created in BioRender. Giesbrecht, K. (2025) https://BioRender.com/k26d165. Thank you to Kathryn Scherrer for proof-reading and editing the manuscript. 

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

This work is supported by the American Heart Association Predoctoral fellowship 899419 to K Giesbrecht. 

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

Additional Editor Comments:

The manuscript presents interesting results on a very relevant topic and deserves to be published. However, it undergoes several weaknesses outlined by both reviewers. One of the reviewers addressed more critical remarks than the other one, but both pointed out important issues that should be considered by the authors.

In my opinion, the authors need to rework the present manuscript by reformulating some statements in order to incorporate in the text most of the reviewer’s observations. References to previous works should be included and, of course, more limitations to the present findings should also be identified in the manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: No

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: N/A

Reviewer #2: N/A

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1:  This paper deals with the challenge of understanding congenital heart defects (CHDs). Less than a third of CHDs have known genetic or environmental causes. Hemodynamic forces, such as wall shear stress, influence heart development but are difficult to measure in vivo. To address this, the authors developed a computational fluid dynamics (CFD) modeling pipeline. This approach numerically simulates blood flow and computes hemodynamic forces in 3D reconstructions of embryonic chick hearts. The method integrates light sheet microscopy and geometric morphometric analysis for anatomical variability. The authors claim that the approach offers a fast, robust tool to study the origins of CHDs.

The paper is technically sound, meaningful, and relevant, presenting new ideas and concepts. Overall, it merits publication, provided the following questions are addressed. 1.The computational pipeline is applied to chick embryos. How can the findings and methodology be translated to humans? This includes not only the procedural aspects but also the implications of the findings, which remain unclear. 2.Regarding the numerical simulations, it is stated that a laminar flow model is considered. Does this imply that no turbulence model is employed? However, would a turbulence model be truly necessary given the nature of blood flow and the resolution of the computational mesh? 3.Unsteady flow is considered in a fixed computational domain. Is it correct? 4.The inflow and outflow boundary conditions are briefly mentioned, but their implementation lacks clarity. Given that the flow is highly sensitive to these boundary conditions, the numerical results—particularly the mean velocity and wall shear stress—can be significantly influenced by their choice. How robust are the results and, consequently, the study’s findings under these assumptions? 5.Geometrical imprecision in the geometrical model can significantly impact the results of numerical simulations. How do such inaccuracies affect the robustness and reliability of the findings? Has this been quantified or accounted for in the analysis?

Reviewer #2:  This paper represents an attempt at quantifying morphology and blood flow in a developing chick embryo extraembryonic vessels. The authors developed a procedure that uses light sheet microscopy to image the chick embryo vessels at early stages of development (HH16-HH17), when the heart is still tubular and connects to the aortic sac from where aortic arches branch that then end in the dorsal aorta. The anatomy of the arches has been described before, and the authors use their developed procedures to show variations in vessel morphology among embryos using morphometric methods. They then use the reconstructed 3D vessel geometry to run CFD simulations to determine flow characteristics.

Unfortunately, some of the procedures employed by the authors are not properly implemented. This, together with lack of proper knowledge of previous works leads to over-exagerated claims for the results achieved, as well as the innovation of the work.

Similar work - using slightly different tools - has been implemented by several groups, including the Butcher group at Cornell, and Pekkan and Keller groups. Light sheet microscopy has also been implemented in the living zebra fish embryo heart - and CFD models (with moving walls - more advanced than the ones by the author) have been developed by Marsden at Stanford and Yap in the UK. 4D reconstructions of the heart have also been achieved using OCT imaging by several groups, including groups at Baylor and Case Western, and wall shear stresses have been estimated from measured flow and through CFD of the moving heart. All these works are grossly minimized or neglected by the authors, who point to "lack of protocols" - and who claim their methods are superior, as nobody could before calculate flow or wall shear stress. In fact their Table 1 omits several works.

CFD models employed by the authors are not validated, and meshes employed are not rigorously tested through a convergence study. Moreover, the geometry employed and boundary conditions do not seem appropriate. CFD boundary conditions are not shown - and comparisons with actual velocity measurements are not used to validate the model results.

The authors start talking about the heart and flow in the heart - but end up modeling only the heart outflow tract and the extracardiac aortic arches and dorsal aorta. It would be more appropriate to neglect the heart outflow tract portion, as it is wrongly captured from fixed embryos (see below). In the authors' models, it would make more sense to start with the aortic sac, then model the conection to the arches and then the aorta. All these are relatively 'fix' portions of vasculature in the embryos.

The outflow tract is a very dynamic cardiac structure: it opens and closes during the cardiac cycle as blood flows through it. But instead of modeling this motion, the authors chose a static (fix) geometry. While this might be a fair approximation (and certainly employed before from CT images) - the procedures employed by the authors to fix the embryos do not seem to arrest the heart properly. The authors mention "the degree of stenosis in the outflow tract" that is apparently different among samples. This likely reflects the fact that the outflow tract of different embryos is arrested at different points in the cardiac cycle (e.g. open outflow tract, semi-closed outflow tract) given the impression that sometimes the outflow tract has "stenosis". There is no "stenosis" in a normal outflow tract - what the authors observed are the outflow tract cushions that are more or less obvious depending on how close or open the outflow tract walls are. The authors should be aware of anatomy and motion of the outflow tract and its implications before attempting to model it. In their models, it would be simpler to neglect the outflow tract.

Authors also mention that vessels have an elliptical cross-sections - how do they know this is not an artifact from the embryo fixation, and/or imaging?

Later in the paper, the authors are then "surprised" to find that regions of high flow velocities also corresponds to regions of high wall shear stress, and that inertia effects are negligible. This is simply due to the low flow Reynolds number. This is not surprising given the small size of the embryo and its heart adn vasculature.

Overall, the more interesting contribution of the paper is in the morphological evaluations of the arches and dorsal aorta anatomy. The CFD models are interesting, but their implementation is not appropriate and simulations have not been validated, nor rigorously tested.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

As requested in the Decision Letter sent on Friday January 17th, we have created a point-by-point response to the reviewer comments and uploaded that response to the revised submission package.

Attachments
Attachment
Submitted filename: Reviewer_Response_PLOS_ONE.docx
Decision Letter - Adélia Sequeira, Editor

An anatomically informed computational fluid dynamics modeling approach for quantifying hemodynamics in the developing heart

PONE-D-24-51917R1

Dear Dr. Bressan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Adélia Sequeira, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors have adequately responded to the comments raised by the reviewers.

The revised version of the manuscript has been significantly improved. 

Reviewers' comments:

Formally Accepted
Acceptance Letter - Adélia Sequeira, Editor

PONE-D-24-51917R1

PLOS ONE

Dear Dr. Bressan,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Adélia Sequeira

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .